N-Myc induces an EZH2-mediated transcriptional program driving Neuroendocrine Prostate Cancer
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 38 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- Prostate cancerThis series is part of our curated briefing on it.
- Samples
- 38 samples: 12 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE86532_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA342161 and SRA study SRP087491. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 31 samples.
How we read this: 12 replicated groups read from 38 sample titles; they account for 31 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM2305218 LNCaP Ctrl 1 LNCaP Ctrl
- GSM2305219 LNCaP Ctrl 2 LNCaP Ctrl
- GSM2305220 LNCaP Ctrl 3 LNCaP Ctrl
- GSM2305221 LnCaP N-Myc 1 LnCaP N-Myc
- GSM2305222 LnCaP N-Myc 2 LnCaP N-Myc
- GSM2305223 LnCaP N-Myc 3 LnCaP N-Myc
- GSM2305224 LnCaP N-Myc 4 LnCaP N-Myc
- GSM2305225 T2-Cre - Sample_PTENf/f_LSLMYCN-/-_1 T2-Cre - Sample_PTENf/f…
- GSM2305226 T2-Cre - Sample_PTENf/f_LSLMYCN-/-_2 T2-Cre - Sample_PTENf/f…
- GSM2305227 T2-Cre - Sample_PTENf/f_LSLMYCN+/+_1 T2-Cre - Sample_PTENf/f…
- GSM2305228 T2-Cre - Sample_PTENf/f_LSLMYCN+/+_2 T2-Cre - Sample_PTENf/f…
- GSM2305229 pbCre - Sample_PTEN+/+_LSLMYCN-/-_1 pbCre - Sample_PTEN+/+_…
- GSM2305230 pbCre - Sample_PTEN+/+_LSLMYCN-/-_2 pbCre - Sample_PTEN+/+_…
- GSM2305231 pbCre - Sample_PTEN+/+_LSLMYCN-/-_3 pbCre - Sample_PTEN+/+_…
- GSM2305232 pbCre - Sample_PTEN+/+_LSLMYCN+/+_1 pbCre - Sample_PTEN+/+_…
- GSM2305233 pbCre - Sample_PTEN+/+_LSLMYCN+/+_2 pbCre - Sample_PTEN+/+_…
- GSM2305234 pbCre - Sample_PTENf/f_LSLMYCN+/+_1 pbCre - Sample_PTENf/f_…
- GSM2305235 pbCre - Sample_PTENf/f_LSLMYCN+/+_2 pbCre - Sample_PTENf/f_…
- GSM2305236 organoids_pbCre+/+_Ptenf/f_LSL-MYCN+/+_1 organoids_pbCre+/+_Pten…
- GSM2305237 organoids_pbCre+/+_Ptenf/f_LSL-MYCN+/+_2 organoids_pbCre+/+_Pten…
- GSM2305238 organoids_pbCre+/+_Ptenf/f_LSL-MYCN+/+_3 organoids_pbCre+/+_Pten…
- GSM2305239 organoids_pbCre+/+_Ptenf/f_LSL-MYCN-/-_1 organoids_pbCre+/+_Pten…
- GSM2305240 organoids_pbCre+/+_Ptenf/f_LSL-MYCN-/-_2 organoids_pbCre+/+_Pten…
- GSM2305241 organoids_pbCre+/+_Ptenf/f_LSL-MYCN-/-_3 organoids_pbCre+/+_Pten…
- GSM2305242 22RV1_Ctrl_1 22RV1_Ctrl
- GSM2305243 22RV1_Ctrl_2 22RV1_Ctrl
- GSM2305244 22RV1_Ctrl_3 22RV1_Ctrl
- GSM2305245 22RV1_N-Myc_1 22RV1_N-Myc
- GSM2305246 22RV1_N-Myc_2 22RV1_N-Myc
- GSM2305247 Input_LNCaP_N-Myc
- GSM2305248 Input_LNCaP_Ctrl
- GSM2305249 IP_H3K27me3_LNCaP-N-Myc
- GSM2305250 IP_H3K27me3_LNCaP-Ctrl
- GSM2305251 LNCaP_N-Myc_siCtrl
- GSM2305252 LNCaP_N-Myc_siEzh2
- GSM2305253 LNCaP_N-Myc_vehicule
- GSM2305254 LNCaP_N-Myc_GSK343#1 LNCaP_N-Myc_GSK343#
- GSM2305255 LNCaP_N-Myc_GSK343#2 LNCaP_N-Myc_GSK343#
- GSE115501 RNA sequencing on circulating tumor cells from prostate cancer patients 136 samples same disease briefing · shares prostate
- GSE222467 The RNA binding proteins LARP4A and LARP4B promote tumour growth and metastasis in prostate cancer and osteosarcoma 12 samples same disease briefing · shares prostate
- GSE300947 A novel six-biomarker panel identified from male breast cancer-associated fibroblasts demonstrates prognostic power for prostate tumors 6 samples same disease briefing · shares prostate
- GSE120181 Human prostate cancer cell line, 22Rv1: Control vs. luteolin treatment 2 samples same disease briefing · shares prostate
- GSE71008 Plasma extracellular RNA profiles in healthy and cancer patients 192 samples same disease briefing
- GSE242541 ONECUT2 is a druggable driver of luminal to basal breast cancer plasticity 12 samples same disease briefing
- GSE289247 Crosstalk between the polycomb repressive complex 2 and DNA methylation mediates neuroendocrine prostate cancer lineage plasticity [ChIP-Seq] 35 samples shares neuroendocrine, prostate
- GSE282726 FOXA1 loss drives basal/squamous de-differentiation of prostate cancer and induces an immunosuppressive tumor microenvironment 25 samples shares prostate, induces
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.